(Q73613497)
Statements
An individual patient-based meta-analysis of tamoxifen versus ovarian ablation as first line endocrine therapy for premenopausal women with metastatic breast cancer (English)
M Crump
C A Sawka
G DeBoer
R B Buchanan
J Forbes
J W Meakin
W Shelley